371 related articles for article (PubMed ID: 33417072)
1. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.
Felmlee MA; Morse BL; Morris ME
AAPS J; 2021 Jan; 23(1):22. PubMed ID: 33417072
[TBL] [Abstract][Full Text] [Related]
2. Drug-drug interaction between diclofenac and gamma-hydroxybutyric acid.
Rodriguez-Cruz V; Ren T; Morris ME
Biopharm Drug Dispos; 2021 Sep; 42(8):351-358. PubMed ID: 34191301
[TBL] [Abstract][Full Text] [Related]
3. Treatment of
Follman KE; Morris ME
J Pharmacol Exp Ther; 2019 Jul; 370(1):84-91. PubMed ID: 31010842
[TBL] [Abstract][Full Text] [Related]
4. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome.
Busardò FP; Jones AW
Curr Neuropharmacol; 2015 Jan; 13(1):47-70. PubMed ID: 26074743
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
[TBL] [Abstract][Full Text] [Related]
6. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of γ-hydroxybutyrate and γ-butyrolactone.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Apr; 345(1):102-10. PubMed ID: 23392755
[TBL] [Abstract][Full Text] [Related]
7. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.
Bhattacharya I; Boje KM
J Pharmacol Exp Ther; 2004 Oct; 311(1):92-8. PubMed ID: 15173314
[TBL] [Abstract][Full Text] [Related]
8. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.
Cui D; Morris ME
Drug Metab Dispos; 2009 Jul; 37(7):1404-10. PubMed ID: 19389857
[TBL] [Abstract][Full Text] [Related]
9.
Rodriguez-Cruz V; Morris ME
J Pharmacol Exp Ther; 2021 Jul; 378(1):42-50. PubMed ID: 33963018
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate.
Morse BL; Vijay N; Morris ME
AAPS J; 2014 Jul; 16(4):756-70. PubMed ID: 24854892
[TBL] [Abstract][Full Text] [Related]
11. A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.
Vijay N; Morse BL; Morris ME
Pharm Res; 2015 Jun; 32(6):1894-906. PubMed ID: 25480120
[TBL] [Abstract][Full Text] [Related]
12. γ-Hydroxybutyric Acid (GHB) Pharmacokinetics and Pharmacodynamics: Semi-Mechanistic and Physiologically Relevant PK/PD Model.
Dave RA; Follman KE; Morris ME
AAPS J; 2017 Sep; 19(5):1449-1460. PubMed ID: 28653244
[TBL] [Abstract][Full Text] [Related]
13. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
14. Toxicokinetics/Toxicodynamics of γ-hydroxybutyrate-ethanol intoxication: evaluation of potential treatment strategies.
Morse BL; Morris ME
J Pharmacol Exp Ther; 2013 Sep; 346(3):504-13. PubMed ID: 23814094
[TBL] [Abstract][Full Text] [Related]
15. GHB Pharmacology and Toxicology: From Metabolism and Pharmacokinetics to Applications: In Clinical and Forensic Toxicology.
Busardò FP; Vergallo GM; Plazzi G
Curr Drug Metab; 2018; 19(13):1054-1055. PubMed ID: 30484395
[No Abstract] [Full Text] [Related]
16. Gamma-hydroxybutyrate abuse: pharmacology and poisoning and withdrawal management.
Marinelli E; Beck R; Malvasi A; Lo Faro AF; Zaami S
Arh Hig Rada Toksikol; 2020 Mar; 71(1):19-26. PubMed ID: 32597141
[TBL] [Abstract][Full Text] [Related]
17. The Drug of Abuse Gamma-Hydroxybutyric Acid Exhibits Tissue-Specific Nonlinear Distribution.
Felmlee MA; Morse BL; Follman KE; Morris ME
AAPS J; 2017 Dec; 20(1):21. PubMed ID: 29280004
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression.
Morse BL; Chadha GS; Felmlee MA; Follman KE; Morris ME
Am J Drug Alcohol Abuse; 2017 Nov; 43(6):686-693. PubMed ID: 28662343
[TBL] [Abstract][Full Text] [Related]
20. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]